1. Home
  2. MREO vs GRVY Comparison

MREO vs GRVY Comparison

Compare MREO & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • GRVY
  • Stock Information
  • Founded
  • MREO 2015
  • GRVY 2000
  • Country
  • MREO United Kingdom
  • GRVY South Korea
  • Employees
  • MREO N/A
  • GRVY N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • GRVY Business Services
  • Sector
  • MREO Health Care
  • GRVY Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • GRVY Nasdaq
  • Market Cap
  • MREO 424.5M
  • GRVY 421.6M
  • IPO Year
  • MREO N/A
  • GRVY 2005
  • Fundamental
  • Price
  • MREO $2.65
  • GRVY $64.31
  • Analyst Decision
  • MREO Strong Buy
  • GRVY
  • Analyst Count
  • MREO 7
  • GRVY 0
  • Target Price
  • MREO $7.71
  • GRVY N/A
  • AVG Volume (30 Days)
  • MREO 977.7K
  • GRVY 11.5K
  • Earning Date
  • MREO 05-13-2025
  • GRVY 05-09-2025
  • Dividend Yield
  • MREO N/A
  • GRVY N/A
  • EPS Growth
  • MREO N/A
  • GRVY N/A
  • EPS
  • MREO N/A
  • GRVY 7.83
  • Revenue
  • MREO N/A
  • GRVY $339,753,162.00
  • Revenue This Year
  • MREO N/A
  • GRVY N/A
  • Revenue Next Year
  • MREO $54.07
  • GRVY N/A
  • P/E Ratio
  • MREO N/A
  • GRVY $8.18
  • Revenue Growth
  • MREO N/A
  • GRVY N/A
  • 52 Week Low
  • MREO $1.58
  • GRVY $53.12
  • 52 Week High
  • MREO $5.02
  • GRVY $88.85
  • Technical
  • Relative Strength Index (RSI)
  • MREO 63.52
  • GRVY 53.35
  • Support Level
  • MREO $2.11
  • GRVY $63.45
  • Resistance Level
  • MREO $2.27
  • GRVY $66.14
  • Average True Range (ATR)
  • MREO 0.14
  • GRVY 1.69
  • MACD
  • MREO 0.03
  • GRVY -0.21
  • Stochastic Oscillator
  • MREO 94.74
  • GRVY 28.00

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About GRVY GRAVITY Co. Ltd. American Depository Shares

GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.

Share on Social Networks: